Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Orthopaedic Surgery Outcomes
Orthopaedic Surgery ACS NSQIP Outcomes
January 1, 2021 – December 31, 2021
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 598 participating sites.
| Orthopaedic Surgery (598 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 580 | 0.34% | 0.36% |
| 30 Day Morbidity | 580 | 3.45% | 4.02% |
| Cardiac | 580 | 0.34% | 0.39% |
| Pneumonia | 580 | 1.03% | 0.50% |
| Unplanned Intubation | 580 | 0.34% | 0.26% |
| Ventilator > 48 Hours | 580 | 0.17% | 0.13% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 580 | 2.07% | 0.98% |
| Renal Failure | 580 | 0.86% | 0.29% |
| Urinary Tract Infection (UTI) | 580 | 0.52% | 0.64% |
| Surgical Site Infection (SSI) | 580 | 0.86% | 1.78% |
| Sepsis | 579 | 0.35% | 0.46% |
| C.diff Colitis | 580 | 0.17% | 0.09% |
| Return to Operating Room (ROR) | 580 | 0.86% | 2.37% |
| Readmission | 580 | 5.86% | 4.64% |
American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.
